MedPage Today | Long-Release Tacrolimus Wins FDA Nod MedPage Today Specific indications for the extended-release form are for prophylaxis of graft rejection in kidney transplant patients also receiving mycophenolate mofetil and corticosteroids, with or without basiliximab (Simulect) induction, the company said ... New Treatment Option for Kidney Transplant Recipients U.S. Launch of Astellas Astagraf XL FDA approves Astellas once-daily organ rejection drug |
